Secondary Degeneration of Auditory Neurons after Topical Aminoglycoside Administration in a Gerbil Model

Area of Science:

• Ototoxic drug-induced secondary degeneration in the cochlea.
• Auditory neuroscience and otolaryngology research.

Background:

• Damage to cochlear hair cells can cause sequential auditory pathway degeneration, known as secondary degeneration.
• Secondary degeneration models in animals are crucial for evaluating cochlear implant efficacy.
• A standardized animal model for secondary degeneration is currently lacking.

Purpose of the Study:

• To develop and validate a novel gerbil model for inducing secondary degeneration in the cochlea using an ototoxic drug.
• To assess the efficacy of different administration methods for inducing consistent hair cell and spiral ganglion neuron damage.

Main Methods:

• 35 gerbils were divided into four groups and treated with kanamycin via different administration routes.
• Auditory brainstem response (ABR) was measured periodically post-treatment.
• Spiral ganglion cells (SGCs) were counted to quantify secondary degeneration.

Main Results:

• Kanamycin treatment damaged both outer and inner hair cells across all groups.
• The round window membrane injection group exhibited significant variability in hair cell and SGC damage.
• Consistent and severe hair cell and SGC damage was observed in the gelfoam group 12 weeks post-treatment.

Conclusions:

• A reproducible gerbil model for inducing secondary degeneration in cochlear hair cells was successfully established.
• The gelfoam administration method provides a consistent model for studying secondary degeneration.
• This model is suitable for research on hearing loss treatments and preservation strategies, including cochlear implant research.